Back to LBRX
UBS Group AG LBRX Position History
LB Pharmaceuticals Inc • Healthcare
Quarters held
10
Latest value
$28K
Q3 2026
Peak value
$8.5M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $17K |
| Q4 2025 | $1.1M |
| Q4 2025 | $16K |
| Q1 2026 | $4K |
| Q1 2026 | $3.4M |
| Q2 2026 | $5K |
| Q2 2026 | $2.8M |
| Q3 2026 | $6K |
| Q3 2026 | $8.5M |
| Q3 2026 | $28K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $28K | 739 | — | — |
| Q3 2026 | $8.5M | 220.3K | — | — |
| Q3 2026 | $6K | 157 | — | — |
| Q2 2026 | $2.8M | 85.8K | — | — |
| Q2 2026 | $5K | 157 | — | — |
| Q1 2026 | $3.4M | 137.8K | — | — |
| Q1 2026 | $4K | 157 | — | — |
| Q4 2025 | $16K | 730 | — | — |
| Q4 2025 | $1.1M | 50.0K | — | — |
| Q3 2025 | $17K | 1.1K | — | — |
Other funds holding LBRX
$128.7M
$108.8M
$82.7M
$74.6M
$53.9M